These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults. Watanabe T; Honda T; Totsuka H; Yoshida M; Tanioka M; Shiraishi K; Shimada Y; Arai E; Ushiama M; Tamura K; Yoshida T; Kanai Y; Kohno T Breast Cancer Res Treat; 2020 Jul; 182(2):491-502. PubMed ID: 32488393 [TBL] [Abstract][Full Text] [Related]
9. The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer. Hjortkjær M; Malik Aagaard Jørgensen M; Waldstrøm M; Ørnskov D; Søgaard-Andersen E; Jakobsen A; Dahl-Steffensen K Int J Gynecol Cancer; 2019 Jan; 29(1):166-173. PubMed ID: 30640700 [TBL] [Abstract][Full Text] [Related]
10. Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and Telli ML; Chu C; Badve SS; Vinayak S; Silver DP; Isakoff SJ; Kaklamani V; Gradishar W; Stearns V; Connolly RM; Ford JM; Gruber JJ; Adams S; Garber J; Tung N; Neff C; Bernhisel R; Timms KM; Richardson AL Clin Cancer Res; 2020 Jun; 26(11):2704-2710. PubMed ID: 31796517 [TBL] [Abstract][Full Text] [Related]
11. TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer. Isakoff SJ; Mayer EL; He L; Traina TA; Carey LA; Krag KJ; Rugo HS; Liu MC; Stearns V; Come SE; Timms KM; Hartman AR; Borger DR; Finkelstein DM; Garber JE; Ryan PD; Winer EP; Goss PE; Ellisen LW J Clin Oncol; 2015 Jun; 33(17):1902-9. PubMed ID: 25847936 [TBL] [Abstract][Full Text] [Related]
12. Homologous recombination deficiency in triple negative breast cancer. Belli C; Duso BA; Ferraro E; Curigliano G Breast; 2019 Jun; 45():15-21. PubMed ID: 30818144 [TBL] [Abstract][Full Text] [Related]
13. Response to olaparib in metastatic lung adenocarcinoma with germline BRCA2 mutation: a case report. Wu C; Fan M; Hu Y Anticancer Drugs; 2022 Jan; 33(1):e734-e737. PubMed ID: 34387603 [TBL] [Abstract][Full Text] [Related]
14. Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival. Kahn RM; Selenica P; Boerner T; Roche KL; Xiao Y; Sia TY; Maio A; Kemel Y; Sheehan M; Salo-Mullen E; Breen KE; Zhou Q; Iasonos A; Grisham RN; O'Cearbhaill RE; Chi DS; Berger MF; Kundra R; Schultz N; Ellenson LH; Stadler ZK; Offit K; Mandelker D; Aghajanian C; Zamarin D; Sabbatini P; Weigelt B; Liu YL Gynecol Oncol; 2024 Jan; 180():35-43. PubMed ID: 38041901 [TBL] [Abstract][Full Text] [Related]
15. Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiAD. Hodgson D; Lai Z; Dearden S; Barrett JC; Harrington EA; Timms K; Lanchbury J; Wu W; Allen A; Senkus E; Domchek SM; Robson M Ann Oncol; 2021 Dec; 32(12):1582-1589. PubMed ID: 34500047 [TBL] [Abstract][Full Text] [Related]
16. Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation. Wattenberg MM; Asch D; Yu S; O'Dwyer PJ; Domchek SM; Nathanson KL; Rosen MA; Beatty GL; Siegelman ES; Reiss KA Br J Cancer; 2020 Feb; 122(3):333-339. PubMed ID: 31787751 [TBL] [Abstract][Full Text] [Related]
17. The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy. Lee SM; Upadhyay S; Lewanski C; Falk S; Skailes G; Woll PJ; Hatton M; Lal R; Jones R; Toy E; Rudd R; Ngai Y; Edwards A; Hackshaw A Eur J Cancer; 2019 Oct; 120():86-96. PubMed ID: 31499384 [TBL] [Abstract][Full Text] [Related]
18. Biomarker Assessment of HR Deficiency, Tumor Stronach EA; Paul J; Timms KM; Hughes E; Brown K; Neff C; Perry M; Gutin A; El-Bahrawy M; Steel JH; Liu X; Lewsley LA; Siddiqui N; Gabra H; Lanchbury JS; Brown R Mol Cancer Res; 2018 Jul; 16(7):1103-1111. PubMed ID: 29724815 [TBL] [Abstract][Full Text] [Related]
19. A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies. Shao C; Wan J; Lam FC; Tang H; Marley AR; Song Y; Miller C; Brown M; Han J; Adeboyeje G Environ Mol Mutagen; 2022 Jul; 63(6):308-316. PubMed ID: 36054589 [TBL] [Abstract][Full Text] [Related]
20. Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma. Takeuchi S; Doi M; Ikari N; Yamamoto M; Furukawa T Sci Rep; 2018 May; 8(1):8105. PubMed ID: 29802286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]